MFX

1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Find entries where: MFX

is present as a standalone ligand in 8 entries

Find related ligands:

Chemical Component Summary
Name	1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Synonyms	moxifloxacin
Identifiers	7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid
Formula	C₂₁ H₂₄ F N₃ O₄
Molecular Weight	401.431
Type	NON-POLYMER
Isomeric SMILES	COc1c2c(cc(c1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
InChI	InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
InChIKey	FABPRXSRWADJSP-MEDUHNTESA-N

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	57
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB00218
Name	Moxifloxacin
Groups	approved investigational
Description	Moxifloxacin is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.
Synonyms	Moxifloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid Moxifloxacin hydrochloride Moxifloxacin hydrochloride monohydrate Moxifloxacino
Brand Names	Moxifloxacin Hydrochloride Tablets, 400 mg Mylan-moxifloxacin Torrent-moxifloxacin Moxifloxacin Ophthalmic Moxifloxacin ophthalmic solution Moxifloxacin Dex-Moxi PF Ag-moxifloxacin Ipg-moxifloxacin Dom-moxifloxacin Riva-moxifloxacin Jamp-moxifloxacin Moxifloxacin PF Dex-Moxi-Ketor Moxifloxacin Ophthalmic Solution Act Moxifloxacin Jamp-moxifloxacin Tablets PHL-moxifloxacin Avelox I.V. Triamcinolone-Moxifloxacin PF Bio-moxifloxacin Avelox DexMoxiKetor PF Sandoz Moxifloxacin PMS-moxifloxacin Moxifloxacin Hydrochloride Priva-moxifloxacin Auro-moxifloxacin Apo-moxifloxacin Apo-moxifloxacin Hydrochloride Dex-Moxi Moxifloxacin Injection Moxeza Med-moxifloxacin Mar-moxifloxacin M-moxifloxacin Teva-moxifloxacin Ixoba M Avelox ABC Pack Vigamox Mylan-moxifloxacin HCl Ophthalmic Solution
Indication	For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).
Categories	Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (moderate) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Fluoroquinolone Antibacterial Fluoroquinolones Heterocyclic Compounds, Fused-Ring Moderate Risk QTc-Prolonging Agents Ophthalmologicals QTc Prolonging Agents Quinolines Quinolone Antimicrobial Quinolones Sensory Organs Topoisomerase II Inhibitors Topoisomerase Inhibitors
ATC-Code	S01AE07 J01MA14
CAS number	151096-09-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
DNA gyrase subunit A	MTDSIQSSITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVL...	unknown	inhibitor
DNA topoisomerase 4 subunit A	MTNINYEGIEQMPLRTFTEKAYLNYSMYVIMDRALPFIGDGLKPVQRRIV...	unknown	inhibitor
DNA topoisomerase 2-alpha	MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY...	unknown	inhibitor
Serum paraoxonase/arylesterase 1	MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIET...	unknown	inhibitor
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682